NIH-funded research R21 grant

Developing advanced phage-based sensors for detecting bacteria

Official title: Bioengineering Phage-based Biosensors with Genetic Specificity and High Sensitivity

Funded at Cornell University · NIH-10727412 · Data updated 2026-11-12

This study is working on creating special viruses that can help doctors quickly and accurately find harmful bacteria and their resistance to antibiotics, which could lead to better treatments for patients with bacterial infections.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionCornell University
NIH-funded
Lab location1 site (Ithaca, United States)
Project startAugust 1, 2023
Project endJuly 31, 2026
Funding year2023
Award (this year)$187,784
NIH project number1R21EB034941-01
Project IDNIH-10727412 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with bacterial infections or those at risk of such infections, particularly those with antibiotic-resistant strains.

Less likely to help

Patients with viral infections or non-bacterial diseases may not receive any benefit from this research.

What this research studies

This research focuses on engineering bacteriophages, which are viruses that specifically target bacteria, to create highly sensitive biosensors. By modifying these phages to express specific reporter proteins during their infection process, the researchers aim to enhance the detection of bacterial genetic material, including genes related to pathogenicity and antibiotic resistance. The approach utilizes synthetic biology techniques to improve the specificity and sensitivity of these biosensors, making them capable of providing rapid and accurate results with minimal resource requirements. Patients could benefit from improved diagnostics for bacterial infections, leading to better-targeted treatments.

Why it matters

Potential benefit: If successful, this research could lead to more accurate and rapid detection of bacterial infections, improving patient outcomes through timely and effective treatment.

How similar studies have gone: Previous research has shown promise in using engineered phages for biosensing, indicating that this approach has potential for success.

Where this research is happening

  • Cornell University
    Ithaca, United States
    Active

Researchers

  • Principal investigator: Nugen, Sam R — Cornell University
  • Study coordinator: Nugen, Sam R

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.